Arslan Mustafa, Celep Bahadır, Ciçek Ramazan, Kalender Hülya Üstün, Yılmaz Hüseyin
Department of Anesthesiology and Reanimation, Gazi University Medical Faculty, Ankara, Turkey.
J Res Med Sci. 2013 Mar;18(3):172-7.
The purpose of the present study was to determine the post-operative analgesic effects of preemptive intravenous (iv) paracetamol and the amount of reduction in tramadol (Contramal(®)) consumption.
Following local research ethics committee approval, ASAI-II, 300 patients were assigned in a randomized manner into three groups: Group I (preemptive) received iv paracetamol 1 g/100 mL 10 min before skin inscision and 100 mL of saline solution at the end of the operation, Group II (post-operative) received 100 mL of saline solution 10 min before skin inscision and iv paracetamol 1 g/100 mL at the end of the operation and Group III (placebo) received 100 mL of saline solution 10 min before skin insicision and 100 mL of saline solution at the end of the operation as well. The time to first analgesic requirement use and 24 h total analgesic consumption were recorded. Visual analog scale (VAS) pain scores were obtained from all patients at 15, 30, min 1, 2, 4, 6, 8, 12 and 24 h after the end of the operation.
Time to first analgesic requirement was significantly longer in Group I and Group II, compared to Group III (P < 0.05). Time to first analgesic requirement was significantly longer in Group I compared to Group II (P < 0.05). Total analgesic consumption and postoperative VAS pain scores recorded were significantly lower in Group I and II, compared to Group III. Total analgesic consumption and postoperative VAS pain scores recorded were significantly lower in Group I compared to Group II (P < 0.05).
In conclusion, preemptive iv paracetamol provided effective and reliable pain control after cholecystectomy surgeries and reduced post-operative pain scores, the need for and use of supplementary opioids and the time to first request of analgesics.
本研究的目的是确定静脉注射对乙酰氨基酚超前镇痛的效果以及曲马多(痛力克(®))用量的减少量。
经当地研究伦理委员会批准,将300例ASA I-II级患者随机分为三组:第一组(超前镇痛组)在皮肤切开前10分钟静脉注射1 g/100 mL对乙酰氨基酚,并在手术结束时静脉注射100 mL生理盐水;第二组(术后镇痛组)在皮肤切开前10分钟静脉注射100 mL生理盐水,并在手术结束时静脉注射1 g/100 mL对乙酰氨基酚;第三组(安慰剂组)在皮肤切开前10分钟静脉注射100 mL生理盐水,并在手术结束时静脉注射100 mL生理盐水。记录首次需要使用镇痛药的时间和24小时总镇痛药消耗量。在手术结束后15、30分钟、1、2、4、6、8、12和24小时从所有患者处获取视觉模拟量表(VAS)疼痛评分。
与第三组相比,第一组和第二组首次需要使用镇痛药的时间显著延长(P<0.05)。与第二组相比,第一组首次需要使用镇痛药的时间显著延长(P<0.05)。与第三组相比,第一组和第二组记录的总镇痛药消耗量和术后VAS疼痛评分显著降低。与第二组相比,第一组记录的总镇痛药消耗量和术后VAS疼痛评分显著降低(P<0.05)。
总之,静脉注射对乙酰氨基酚超前镇痛在胆囊切除术后提供了有效且可靠的疼痛控制,降低了术后疼痛评分、补充阿片类药物的需求和使用以及首次要求使用镇痛药的时间。